DSS, Inc (DSS) – Company Press Releases
-
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
-
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
-
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
-
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
-
Impact Biomedical Inc. Files Current Report on Form 8-K
-
DSS Inc. Wins Patent Dispute with Nichia Corporation
-
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock
-
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule
-
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical
-
DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary
-
DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.
-
DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.
-
DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.
-
DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend
-
Presenting on the Emerging Growth Conference on June 14 Register Now
-
DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
-
DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders
-
DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders
-
Presenting on the Emerging Growth Conference on April 19 Register Now
-
DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM
-
DSS Announces Letter to Shareholders
-
Impact BioMedical Scientific Partner GRDG Sciences to be Featured in New Documentary
-
DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing
-
Impact BioMedical Develops Quantum Antihistamine
-
DSS Announces Licensing of Impact BioMedical’s Linebacker Portfolio to ProPhase Labs
-
DSS Strengthens and Expands Board with Appointment of Two Independent Directors
-
Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir
-
DSS’s Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant
-
DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®
-
Impact BioMedical’s Proprietary Equivir Compound to Treat Viral Infection Receives Clean Patentability Report from World Intellectual Property Organization’s ISA Division
-
CORRECTION - DSS Announces Letter to Shareholders
-
DSS Announces Letter to Shareholders
-
DSS to Present at Aegis Virtual Conference
-
DSS Receives $17 Million Investment from Alset EHome International
-
American Premium Water Corp. (OTC:HIPH) Announces the Appointment of John “JT” Thatch to Its Board of Directors
-
American Premium Water Corp. (OTC:HIPH) Announces the Appointment of John “JT” Thatch to Its Board of Directors
-
DSS Acquires 25.1% of Alset International Limited
-
DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building
-
Impact BioMedical Announces New Bioplastics Test Results
-
DSS Retains Leading Blockchain and Digital Assets Law Firm to Accelerate Launch of Digital Asset Exchange
-
Heng Fai Ambrose Chan Joins Value Exchange International, Inc. Board of Directors
-
DSS Provides Update on Expansion of Premier Packaging Subsidiary
-
DSS’s American Pacific Bancorp Approaches $20M in New Loans Issued
-
DSS Opens Sacramento Office for its DSS Wealth Management and DSS AmericaFirst Quantitative Funds
-
DSS to Present at the Emerging Growth Conference on December 8
-
CEOs Presenting at the Emerging Growth Conference on December 8; Register Now
-
DSS Enters Quantitative Investment Fund Arena
-
DSS Expands American Medical REIT with Acquisition of Three Established Acute Care Hospitals in Texas and Pennsylvania
-
DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®
-
DSS Provides Update on its Liquid Value Asset Management Subsidiary
Back to DSS Stock Lookup